| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 190 | 2024 | 2921 | 9.920 |
Why?
|
| Particulate Matter | 187 | 2024 | 2623 | 8.870 |
Why?
|
| Air Pollution | 131 | 2024 | 2379 | 8.220 |
Why?
|
| Environmental Exposure | 145 | 2024 | 4544 | 6.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 60 | 2024 | 2538 | 3.950 |
Why?
|
| Maternal Exposure | 49 | 2024 | 1097 | 3.900 |
Why?
|
| Environmental Monitoring | 70 | 2021 | 1467 | 3.760 |
Why?
|
| Environmental Pollutants | 24 | 2024 | 1294 | 3.180 |
Why?
|
| Soot | 30 | 2024 | 219 | 2.940 |
Why?
|
| Vehicle Emissions | 39 | 2019 | 651 | 2.920 |
Why?
|
| Air Pollution, Indoor | 32 | 2025 | 930 | 2.620 |
Why?
|
| Bayes Theorem | 45 | 2024 | 2352 | 2.480 |
Why?
|
| Inhalation Exposure | 24 | 2020 | 432 | 2.160 |
Why?
|
| Models, Statistical | 38 | 2023 | 5089 | 2.070 |
Why?
|
| Respiratory Tract Diseases | 9 | 2019 | 744 | 1.570 |
Why?
|
| Asthma | 35 | 2024 | 6267 | 1.560 |
Why?
|
| Radon | 8 | 2025 | 90 | 1.490 |
Why?
|
| Birth Weight | 24 | 2023 | 2123 | 1.400 |
Why?
|
| Biostatistics | 4 | 2020 | 162 | 1.340 |
Why?
|
| Biometry | 12 | 2016 | 571 | 1.290 |
Why?
|
| Pregnancy | 123 | 2024 | 30235 | 1.290 |
Why?
|
| DNA Methylation | 28 | 2023 | 4428 | 1.280 |
Why?
|
| Particle Size | 51 | 2023 | 1634 | 1.280 |
Why?
|
| Aircraft | 3 | 2019 | 135 | 1.270 |
Why?
|
| Temperature | 18 | 2024 | 2229 | 1.220 |
Why?
|
| Censuses | 7 | 2023 | 197 | 1.200 |
Why?
|
| Linear Models | 41 | 2021 | 5872 | 1.190 |
Why?
|
| Respiratory Sounds | 10 | 2022 | 702 | 1.180 |
Why?
|
| Metals | 10 | 2023 | 711 | 1.160 |
Why?
|
| Manganese | 12 | 2023 | 393 | 1.140 |
Why?
|
| Air Pollutants, Radioactive | 7 | 2025 | 55 | 1.110 |
Why?
|
| Occupational Diseases | 5 | 2018 | 1456 | 1.100 |
Why?
|
| Radioactivity | 6 | 2023 | 60 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 18 | 2024 | 3245 | 1.050 |
Why?
|
| Boston | 68 | 2024 | 9333 | 1.050 |
Why?
|
| Carbon | 17 | 2016 | 673 | 1.030 |
Why?
|
| Fluorocarbons | 9 | 2023 | 498 | 0.990 |
Why?
|
| Nitrogen Dioxide | 19 | 2024 | 538 | 0.930 |
Why?
|
| Residence Characteristics | 20 | 2024 | 2114 | 0.910 |
Why?
|
| Seasons | 31 | 2024 | 1521 | 0.900 |
Why?
|
| Data Interpretation, Statistical | 16 | 2017 | 2693 | 0.900 |
Why?
|
| Regression Analysis | 17 | 2018 | 6327 | 0.890 |
Why?
|
| Humans | 449 | 2025 | 766432 | 0.870 |
Why?
|
| Arsenic | 8 | 2022 | 357 | 0.870 |
Why?
|
| Mortality | 19 | 2022 | 2907 | 0.810 |
Why?
|
| Aerospace Medicine | 3 | 2018 | 95 | 0.800 |
Why?
|
| Power Plants | 6 | 2011 | 125 | 0.780 |
Why?
|
| Female | 284 | 2024 | 396354 | 0.780 |
Why?
|
| Urban Population | 21 | 2023 | 2038 | 0.770 |
Why?
|
| Male | 276 | 2024 | 363975 | 0.720 |
Why?
|
| Massachusetts | 44 | 2024 | 8885 | 0.720 |
Why?
|
| Housing | 14 | 2025 | 682 | 0.720 |
Why?
|
| Aging | 32 | 2024 | 8725 | 0.700 |
Why?
|
| Hydrocortisone | 8 | 2022 | 1838 | 0.700 |
Why?
|
| Aerosols | 13 | 2018 | 634 | 0.690 |
Why?
|
| Oxidative Stress | 20 | 2023 | 3141 | 0.690 |
Why?
|
| Child Development | 10 | 2020 | 2327 | 0.670 |
Why?
|
| Humidity | 5 | 2024 | 206 | 0.670 |
Why?
|
| Lead | 10 | 2021 | 878 | 0.670 |
Why?
|
| Population Groups | 1 | 2020 | 209 | 0.660 |
Why?
|
| Socioeconomic Factors | 19 | 2024 | 7840 | 0.660 |
Why?
|
| Environmental Health | 4 | 2018 | 297 | 0.630 |
Why?
|
| Computer Simulation | 22 | 2023 | 6259 | 0.630 |
Why?
|
| Homicide | 4 | 2017 | 294 | 0.620 |
Why?
|
| Heart Rate | 19 | 2024 | 4190 | 0.610 |
Why?
|
| Mexico | 16 | 2024 | 771 | 0.600 |
Why?
|
| Aviation | 1 | 2018 | 49 | 0.600 |
Why?
|
| Ozone | 14 | 2024 | 499 | 0.590 |
Why?
|
| Schools | 8 | 2021 | 1495 | 0.590 |
Why?
|
| Alkanesulfonic Acids | 6 | 2023 | 198 | 0.590 |
Why?
|
| Hydrocarbons, Chlorinated | 4 | 2023 | 120 | 0.580 |
Why?
|
| Health Surveys | 9 | 2019 | 4054 | 0.580 |
Why?
|
| Blood Pressure | 17 | 2020 | 8532 | 0.570 |
Why?
|
| DNA, Mitochondrial | 7 | 2021 | 872 | 0.570 |
Why?
|
| Health Status Disparities | 7 | 2020 | 1876 | 0.560 |
Why?
|
| Clothing | 1 | 2018 | 95 | 0.560 |
Why?
|
| Pregnancy Outcome | 6 | 2024 | 2970 | 0.550 |
Why?
|
| Cohort Studies | 69 | 2024 | 41703 | 0.550 |
Why?
|
| Longitudinal Studies | 33 | 2021 | 14760 | 0.540 |
Why?
|
| United States | 84 | 2025 | 72910 | 0.540 |
Why?
|
| Infant, Newborn | 50 | 2024 | 26388 | 0.530 |
Why?
|
| Aged | 139 | 2024 | 171234 | 0.530 |
Why?
|
| Epigenesis, Genetic | 12 | 2024 | 3824 | 0.520 |
Why?
|
| Poverty | 7 | 2024 | 2714 | 0.520 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2019 | 828 | 0.510 |
Why?
|
| Polychlorinated Biphenyls | 3 | 2023 | 235 | 0.510 |
Why?
|
| Flame Retardants | 3 | 2021 | 97 | 0.510 |
Why?
|
| Cardiovascular Diseases | 20 | 2024 | 15639 | 0.510 |
Why?
|
| Stress, Psychological | 13 | 2024 | 4527 | 0.500 |
Why?
|
| Hypersensitivity | 5 | 2019 | 1169 | 0.500 |
Why?
|
| Infant Mortality | 3 | 2015 | 752 | 0.500 |
Why?
|
| Phthalic Acids | 5 | 2024 | 485 | 0.500 |
Why?
|
| Vital Capacity | 8 | 2020 | 995 | 0.500 |
Why?
|
| Occupational Exposure | 5 | 2019 | 1807 | 0.500 |
Why?
|
| Arrhythmias, Cardiac | 10 | 2024 | 2246 | 0.490 |
Why?
|
| Child | 80 | 2024 | 80668 | 0.490 |
Why?
|
| Solar Activity | 4 | 2024 | 44 | 0.480 |
Why?
|
| Airway Obstruction | 1 | 2020 | 672 | 0.480 |
Why?
|
| Fetal Development | 7 | 2023 | 777 | 0.470 |
Why?
|
| Prospective Studies | 61 | 2024 | 54826 | 0.460 |
Why?
|
| Selection Bias | 1 | 2016 | 359 | 0.460 |
Why?
|
| Endocrine Disruptors | 3 | 2024 | 264 | 0.460 |
Why?
|
| Inflammation | 20 | 2024 | 10860 | 0.460 |
Why?
|
| Models, Theoretical | 18 | 2019 | 3562 | 0.460 |
Why?
|
| Epidemiology | 2 | 2018 | 278 | 0.450 |
Why?
|
| Forced Expiratory Volume | 9 | 2020 | 1828 | 0.450 |
Why?
|
| Cognition | 15 | 2024 | 7057 | 0.450 |
Why?
|
| Violence | 3 | 2017 | 931 | 0.440 |
Why?
|
| Human Rights Abuses | 1 | 2013 | 34 | 0.430 |
Why?
|
| Dibutyl Phthalate | 3 | 2018 | 29 | 0.430 |
Why?
|
| Abortion, Legal | 1 | 2015 | 121 | 0.430 |
Why?
|
| Adult | 125 | 2024 | 223253 | 0.430 |
Why?
|
| Lung | 17 | 2022 | 10064 | 0.430 |
Why?
|
| Young Adult | 64 | 2024 | 59928 | 0.420 |
Why?
|
| Causality | 3 | 2021 | 1251 | 0.420 |
Why?
|
| Infant | 41 | 2024 | 36460 | 0.410 |
Why?
|
| Urban Health | 8 | 2020 | 532 | 0.410 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 3403 | 0.410 |
Why?
|
| Veterans | 8 | 2022 | 2667 | 0.400 |
Why?
|
| Middle Aged | 113 | 2024 | 223127 | 0.390 |
Why?
|
| Sulfates | 9 | 2017 | 380 | 0.390 |
Why?
|
| Environment | 4 | 2019 | 1120 | 0.390 |
Why?
|
| Cities | 11 | 2020 | 542 | 0.390 |
Why?
|
| Adolescent | 68 | 2024 | 88898 | 0.390 |
Why?
|
| Social Justice | 2 | 2024 | 483 | 0.390 |
Why?
|
| Autonomic Nervous System | 4 | 2019 | 705 | 0.380 |
Why?
|
| Population Dynamics | 1 | 2013 | 314 | 0.380 |
Why?
|
| Menarche | 2 | 2024 | 532 | 0.380 |
Why?
|
| Hazardous Substances | 3 | 2017 | 153 | 0.370 |
Why?
|
| Body Mass Index | 11 | 2024 | 13045 | 0.360 |
Why?
|
| Epigenomics | 4 | 2024 | 959 | 0.360 |
Why?
|
| Aged, 80 and over | 67 | 2024 | 59538 | 0.350 |
Why?
|
| Remote Sensing Technology | 4 | 2017 | 93 | 0.350 |
Why?
|
| Premature Birth | 6 | 2024 | 1830 | 0.350 |
Why?
|
| Child, Preschool | 43 | 2024 | 42576 | 0.340 |
Why?
|
| Hot Temperature | 5 | 2023 | 1442 | 0.340 |
Why?
|
| Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
| Temperament | 3 | 2024 | 300 | 0.340 |
Why?
|
| Toxicity Tests | 6 | 2011 | 112 | 0.330 |
Why?
|
| Gamma Rays | 3 | 2020 | 324 | 0.330 |
Why?
|
| Radiation Monitoring | 4 | 2025 | 106 | 0.330 |
Why?
|
| Phenytoin | 6 | 2005 | 189 | 0.330 |
Why?
|
| Depression | 13 | 2023 | 8229 | 0.330 |
Why?
|
| Dust | 9 | 2024 | 489 | 0.330 |
Why?
|
| Infant, Low Birth Weight | 4 | 2019 | 870 | 0.330 |
Why?
|
| Coal | 7 | 2023 | 123 | 0.320 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6962 | 0.320 |
Why?
|
| Hair | 5 | 2020 | 508 | 0.320 |
Why?
|
| Carbon Monoxide | 8 | 2019 | 560 | 0.320 |
Why?
|
| Skin Diseases | 1 | 2018 | 1083 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2021 | 453 | 0.320 |
Why?
|
| Oxidants, Photochemical | 3 | 2017 | 77 | 0.320 |
Why?
|
| Spacecraft | 4 | 2017 | 28 | 0.310 |
Why?
|
| United States Environmental Protection Agency | 8 | 2020 | 139 | 0.310 |
Why?
|
| Metals, Heavy | 2 | 2016 | 149 | 0.310 |
Why?
|
| Endothelium | 3 | 2020 | 768 | 0.310 |
Why?
|
| Hypertension | 10 | 2020 | 8614 | 0.310 |
Why?
|
| Cross-Over Studies | 12 | 2019 | 2108 | 0.310 |
Why?
|
| Nutrition Surveys | 6 | 2023 | 1735 | 0.310 |
Why?
|
| New England | 8 | 2023 | 1059 | 0.310 |
Why?
|
| Nails | 6 | 2022 | 298 | 0.300 |
Why?
|
| Food Supply | 2 | 2024 | 544 | 0.300 |
Why?
|
| Family Characteristics | 5 | 2023 | 1001 | 0.300 |
Why?
|
| Endotoxins | 3 | 2015 | 519 | 0.300 |
Why?
|
| Menstrual Cycle | 4 | 2024 | 539 | 0.300 |
Why?
|
| Mercury | 3 | 2022 | 289 | 0.300 |
Why?
|
| Live Birth | 2 | 2023 | 516 | 0.300 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 677 | 0.300 |
Why?
|
| Gestational Age | 12 | 2023 | 3617 | 0.290 |
Why?
|
| Hospitalization | 8 | 2024 | 10812 | 0.290 |
Why?
|
| Abnormalities, Drug-Induced | 7 | 2005 | 337 | 0.290 |
Why?
|
| Phenols | 2 | 2024 | 526 | 0.290 |
Why?
|
| Sex Factors | 20 | 2021 | 10614 | 0.280 |
Why?
|
| Income | 5 | 2015 | 1875 | 0.280 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2351 | 0.270 |
Why?
|
| Dogs | 10 | 2017 | 3834 | 0.270 |
Why?
|
| Automobiles | 2 | 2018 | 103 | 0.270 |
Why?
|
| Geologic Sediments | 2 | 2004 | 81 | 0.270 |
Why?
|
| Cause of Death | 5 | 2020 | 3714 | 0.270 |
Why?
|
| Bone Density | 4 | 2020 | 3491 | 0.260 |
Why?
|
| Fetal Blood | 7 | 2019 | 1366 | 0.260 |
Why?
|
| Noise, Transportation | 2 | 2018 | 60 | 0.260 |
Why?
|
| Police | 2 | 2019 | 158 | 0.260 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 299 | 0.260 |
Why?
|
| Cough | 2 | 2024 | 599 | 0.260 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 26294 | 0.260 |
Why?
|
| Infertility, Female | 2 | 2024 | 763 | 0.250 |
Why?
|
| Epidemiologic Methods | 3 | 2008 | 1326 | 0.250 |
Why?
|
| Decanoic Acids | 3 | 2021 | 68 | 0.250 |
Why?
|
| Prenatal Care | 1 | 2013 | 1158 | 0.250 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2016 | 1131 | 0.240 |
Why?
|
| Respiratory Function Tests | 11 | 2020 | 1691 | 0.240 |
Why?
|
| Cluster Analysis | 7 | 2020 | 2718 | 0.240 |
Why?
|
| Obesity | 9 | 2024 | 13088 | 0.240 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 1301 | 0.240 |
Why?
|
| Folic Acid | 4 | 2023 | 1337 | 0.240 |
Why?
|
| Prevalence | 10 | 2019 | 15820 | 0.240 |
Why?
|
| Fibrinogen | 5 | 2017 | 893 | 0.240 |
Why?
|
| Mass Media | 2 | 2017 | 302 | 0.230 |
Why?
|
| Disease Susceptibility | 3 | 2010 | 1791 | 0.230 |
Why?
|
| Smoke | 3 | 2016 | 243 | 0.230 |
Why?
|
| Population Surveillance | 3 | 2014 | 2594 | 0.230 |
Why?
|
| Risk Factors | 41 | 2024 | 74828 | 0.230 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2019 | 301 | 0.230 |
Why?
|
| Incidence | 14 | 2024 | 21509 | 0.230 |
Why?
|
| Bangladesh | 5 | 2019 | 745 | 0.230 |
Why?
|
| Benzophenones | 1 | 2024 | 58 | 0.230 |
Why?
|
| Ventricular Premature Complexes | 3 | 2023 | 108 | 0.220 |
Why?
|
| Myocardial Ischemia | 6 | 2024 | 2127 | 0.220 |
Why?
|
| Telomere | 4 | 2023 | 941 | 0.220 |
Why?
|
| Cooking | 6 | 2016 | 327 | 0.220 |
Why?
|
| Saliva | 4 | 2019 | 852 | 0.220 |
Why?
|
| Time Factors | 28 | 2024 | 40116 | 0.210 |
Why?
|
| Logistic Models | 13 | 2021 | 13276 | 0.210 |
Why?
|
| Heart | 6 | 2019 | 4421 | 0.210 |
Why?
|
| Copper | 2 | 2023 | 365 | 0.210 |
Why?
|
| Water Pollutants, Chemical | 4 | 2017 | 356 | 0.210 |
Why?
|
| Adipokines | 2 | 2017 | 308 | 0.210 |
Why?
|
| Anticonvulsants | 5 | 2005 | 1920 | 0.210 |
Why?
|
| Weather | 5 | 2019 | 234 | 0.210 |
Why?
|
| Myocardial Infarction | 14 | 2022 | 11501 | 0.210 |
Why?
|
| Leukocytes | 4 | 2022 | 2033 | 0.210 |
Why?
|
| Executive Function | 3 | 2022 | 1396 | 0.210 |
Why?
|
| Stroke | 11 | 2023 | 9732 | 0.210 |
Why?
|
| Caprylates | 2 | 2021 | 113 | 0.200 |
Why?
|
| Nickel | 2 | 2020 | 126 | 0.200 |
Why?
|
| Tooth | 2 | 2021 | 210 | 0.200 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 591 | 0.200 |
Why?
|
| Arsenicals | 2 | 2019 | 117 | 0.200 |
Why?
|
| Pregnancy Complications | 5 | 2020 | 2971 | 0.200 |
Why?
|
| Mesalamine | 3 | 2018 | 133 | 0.200 |
Why?
|
| Mumps | 1 | 2023 | 71 | 0.200 |
Why?
|
| Radiation Injuries | 2 | 2020 | 1192 | 0.200 |
Why?
|
| Social Class | 6 | 2016 | 2006 | 0.190 |
Why?
|
| Leukocyte Count | 2 | 2020 | 1606 | 0.190 |
Why?
|
| Malus | 1 | 2022 | 51 | 0.190 |
Why?
|
| Rodent Control | 1 | 2021 | 15 | 0.190 |
Why?
|
| Beta Particles | 2 | 2020 | 52 | 0.190 |
Why?
|
| Facial Bones | 1 | 2003 | 209 | 0.190 |
Why?
|
| Women's Health | 6 | 2023 | 2080 | 0.190 |
Why?
|
| Seawater | 3 | 2016 | 126 | 0.190 |
Why?
|
| Nitrates | 2 | 2017 | 260 | 0.190 |
Why?
|
| Sulfur | 2 | 2017 | 158 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 5 | 2024 | 1478 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2020 | 2270 | 0.190 |
Why?
|
| Parabens | 2 | 2024 | 117 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 10379 | 0.190 |
Why?
|
| Italy | 5 | 2023 | 855 | 0.180 |
Why?
|
| Nurses | 2 | 2023 | 2503 | 0.180 |
Why?
|
| Satellite Communications | 3 | 2015 | 13 | 0.180 |
Why?
|
| Pollen | 1 | 2001 | 80 | 0.180 |
Why?
|
| Aging, Premature | 1 | 2021 | 44 | 0.180 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2022 | 702 | 0.180 |
Why?
|
| Pregnancy Trimesters | 2 | 2023 | 197 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 692 | 0.180 |
Why?
|
| Allergens | 4 | 2021 | 1436 | 0.180 |
Why?
|
| Lymphocyte Count | 2 | 2020 | 794 | 0.180 |
Why?
|
| Tooth, Deciduous | 2 | 2018 | 76 | 0.180 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2018 | 99 | 0.180 |
Why?
|
| Interleukin-6 | 7 | 2024 | 3226 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 2660 | 0.170 |
Why?
|
| Electrocardiography, Ambulatory | 6 | 2009 | 579 | 0.170 |
Why?
|
| Glutathione Transferase | 4 | 2019 | 565 | 0.170 |
Why?
|
| Intelligence | 3 | 2020 | 925 | 0.170 |
Why?
|
| Likelihood Functions | 5 | 2011 | 993 | 0.170 |
Why?
|
| Paternal Exposure | 1 | 2020 | 100 | 0.170 |
Why?
|
| United States Department of Veterans Affairs | 6 | 2017 | 937 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 297 | 0.170 |
Why?
|
| Sample Size | 3 | 2023 | 844 | 0.170 |
Why?
|
| Hemodynamics | 3 | 2015 | 4187 | 0.170 |
Why?
|
| Mining | 2 | 2017 | 93 | 0.170 |
Why?
|
| Selenium | 1 | 2022 | 418 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2024 | 391 | 0.170 |
Why?
|
| Blood Glucose | 3 | 2021 | 6422 | 0.160 |
Why?
|
| ROC Curve | 3 | 2003 | 3616 | 0.160 |
Why?
|
| Quinolinic Acid | 1 | 2019 | 67 | 0.160 |
Why?
|
| Odds Ratio | 12 | 2021 | 9654 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2019 | 587 | 0.160 |
Why?
|
| Leiomyoma | 1 | 2024 | 644 | 0.160 |
Why?
|
| Vitamin B 6 | 2 | 2017 | 237 | 0.160 |
Why?
|
| Meconium | 1 | 2019 | 47 | 0.160 |
Why?
|
| Plant Proteins | 1 | 2001 | 375 | 0.160 |
Why?
|
| Rats | 18 | 2019 | 23718 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 249 | 0.160 |
Why?
|
| Models, Biological | 6 | 2012 | 9458 | 0.150 |
Why?
|
| Age Factors | 17 | 2024 | 18395 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 15 | 2017 | 8107 | 0.150 |
Why?
|
| Postmenopause | 2 | 2019 | 2517 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 536 | 0.150 |
Why?
|
| Climate | 1 | 2019 | 146 | 0.150 |
Why?
|
| Parturition | 2 | 2023 | 453 | 0.150 |
Why?
|
| Risk | 11 | 2019 | 9601 | 0.150 |
Why?
|
| Skull | 1 | 2003 | 819 | 0.150 |
Why?
|
| Alloys | 1 | 2018 | 110 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2018 | 468 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12236 | 0.150 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 1263 | 0.150 |
Why?
|
| Geography | 3 | 2015 | 651 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2023 | 3989 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 1772 | 0.150 |
Why?
|
| Alaska | 1 | 2018 | 68 | 0.150 |
Why?
|
| Dentin | 1 | 2018 | 75 | 0.150 |
Why?
|
| Body Composition | 2 | 2018 | 2441 | 0.150 |
Why?
|
| Calibration | 6 | 2022 | 814 | 0.150 |
Why?
|
| Baroreflex | 2 | 2017 | 153 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 354 | 0.150 |
Why?
|
| Wood | 2 | 2015 | 94 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 29 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 70 | 0.150 |
Why?
|
| Confidence Intervals | 4 | 2019 | 2920 | 0.150 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2019 | 503 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 52 | 0.140 |
Why?
|
| Neutrophils | 5 | 2020 | 3782 | 0.140 |
Why?
|
| Pest Control | 1 | 2017 | 29 | 0.140 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
| Hypospadias | 1 | 2018 | 98 | 0.140 |
Why?
|
| Ecosystem | 1 | 2021 | 489 | 0.140 |
Why?
|
| Cryptorchidism | 1 | 2018 | 152 | 0.140 |
Why?
|
| Vitamin B 12 | 2 | 2017 | 531 | 0.140 |
Why?
|
| Child Behavior | 2 | 2020 | 864 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 68 | 0.140 |
Why?
|
| Iron | 2 | 2023 | 1812 | 0.140 |
Why?
|
| Patient Admission | 2 | 2015 | 1364 | 0.140 |
Why?
|
| Fungi | 2 | 2022 | 346 | 0.140 |
Why?
|
| Binomial Distribution | 1 | 1996 | 23 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 163 | 0.140 |
Why?
|
| Models, Cardiovascular | 2 | 2020 | 977 | 0.140 |
Why?
|
| Pre-Eclampsia | 2 | 2024 | 1256 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 3 | 2021 | 84 | 0.140 |
Why?
|
| Death Certificates | 1 | 2017 | 172 | 0.130 |
Why?
|
| C-Reactive Protein | 9 | 2024 | 3852 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2005 | 2233 | 0.130 |
Why?
|
| Phenobarbital | 5 | 2005 | 192 | 0.130 |
Why?
|
| Herbicides | 1 | 2017 | 104 | 0.130 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.130 |
Why?
|
| Environment Design | 1 | 2018 | 174 | 0.130 |
Why?
|
| Cosmetics | 1 | 2017 | 104 | 0.130 |
Why?
|
| Animals | 39 | 2022 | 168887 | 0.130 |
Why?
|
| Law Enforcement | 1 | 2017 | 112 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 139 | 0.130 |
Why?
|
| Los Angeles | 3 | 2011 | 244 | 0.130 |
Why?
|
| Nitrogen Oxides | 4 | 2017 | 128 | 0.130 |
Why?
|
| Cold Temperature | 2 | 2017 | 795 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 408 | 0.120 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.120 |
Why?
|
| Smoking | 5 | 2019 | 9076 | 0.120 |
Why?
|
| Developing Countries | 2 | 2018 | 2913 | 0.120 |
Why?
|
| Rural Health | 1 | 2017 | 302 | 0.120 |
Why?
|
| Language Development | 1 | 2016 | 183 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 810 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2022 | 1195 | 0.120 |
Why?
|
| Meningomyelocele | 1 | 2017 | 182 | 0.120 |
Why?
|
| Insecticides | 1 | 2017 | 203 | 0.120 |
Why?
|
| Sperm Motility | 1 | 2016 | 264 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 550 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2020 | 665 | 0.120 |
Why?
|
| Georgia | 2 | 2013 | 186 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2024 | 530 | 0.120 |
Why?
|
| Polychaeta | 2 | 2004 | 5 | 0.120 |
Why?
|
| Nasal Mucosa | 1 | 2018 | 416 | 0.120 |
Why?
|
| Fingers | 5 | 2005 | 508 | 0.120 |
Why?
|
| Optical Phenomena | 1 | 2015 | 103 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2016 | 96 | 0.120 |
Why?
|
| Acetaminophen | 1 | 2019 | 549 | 0.120 |
Why?
|
| Minority Health | 1 | 2015 | 79 | 0.120 |
Why?
|
| Pregnant Women | 2 | 2018 | 576 | 0.120 |
Why?
|
| Respiration | 2 | 2011 | 1653 | 0.120 |
Why?
|
| Diet, Reducing | 1 | 2018 | 487 | 0.120 |
Why?
|
| beta-Glucans | 1 | 2015 | 129 | 0.110 |
Why?
|
| Immunoglobulin E | 4 | 2018 | 1495 | 0.110 |
Why?
|
| Nervous System | 1 | 2017 | 542 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 267 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 2 | 2015 | 2672 | 0.110 |
Why?
|
| Proportional Hazards Models | 10 | 2020 | 12527 | 0.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1249 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 39283 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 899 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 578 | 0.110 |
Why?
|
| Psychotic Disorders | 2 | 2022 | 3275 | 0.110 |
Why?
|
| Semen | 1 | 2016 | 349 | 0.110 |
Why?
|
| School Health Services | 1 | 2017 | 388 | 0.110 |
Why?
|
| Radon Daughters | 2 | 2023 | 11 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2022 | 3788 | 0.110 |
Why?
|
| Coronary Artery Disease | 5 | 2016 | 6543 | 0.110 |
Why?
|
| Erectile Dysfunction | 1 | 2017 | 437 | 0.110 |
Why?
|
| Coronary Circulation | 2 | 2010 | 1601 | 0.110 |
Why?
|
| Models, Genetic | 2 | 2020 | 3450 | 0.110 |
Why?
|
| Educational Status | 3 | 2018 | 2510 | 0.110 |
Why?
|
| Neoplasms | 3 | 2020 | 22343 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 401 | 0.110 |
Why?
|
| Life Change Events | 2 | 2015 | 956 | 0.100 |
Why?
|
| Firearms | 2 | 2017 | 630 | 0.100 |
Why?
|
| Parasympathetic Nervous System | 1 | 2013 | 144 | 0.100 |
Why?
|
| Cockroaches | 2 | 2017 | 92 | 0.100 |
Why?
|
| Peroxidase | 1 | 2016 | 610 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2017 | 1404 | 0.100 |
Why?
|
| Colombia | 1 | 2013 | 288 | 0.100 |
Why?
|
| Data Collection | 3 | 2021 | 3321 | 0.100 |
Why?
|
| Rural Population | 4 | 2021 | 2317 | 0.100 |
Why?
|
| Climate Change | 1 | 2019 | 509 | 0.100 |
Why?
|
| Civil Rights | 1 | 2013 | 129 | 0.100 |
Why?
|
| Toes | 2 | 2005 | 209 | 0.100 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2645 | 0.100 |
Why?
|
| SEER Program | 2 | 2015 | 1443 | 0.100 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1889 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2014 | 373 | 0.100 |
Why?
|
| Placenta | 2 | 2023 | 1725 | 0.100 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 755 | 0.100 |
Why?
|
| Longevity | 1 | 2019 | 1085 | 0.100 |
Why?
|
| Retroelements | 1 | 2013 | 163 | 0.100 |
Why?
|
| Transition Elements | 1 | 2011 | 14 | 0.100 |
Why?
|
| Self Report | 3 | 2019 | 3770 | 0.100 |
Why?
|
| Adiposity | 2 | 2019 | 1892 | 0.090 |
Why?
|
| Medicare | 8 | 2024 | 6817 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 2041 | 0.090 |
Why?
|
| Alkanes | 1 | 2011 | 39 | 0.090 |
Why?
|
| Brain Ischemia | 3 | 2013 | 3000 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 1398 | 0.090 |
Why?
|
| Silicones | 2 | 2022 | 228 | 0.090 |
Why?
|
| State Health Plans | 1 | 2013 | 220 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2017 | 810 | 0.090 |
Why?
|
| Macrophages, Alveolar | 2 | 2006 | 413 | 0.090 |
Why?
|
| Software | 2 | 2018 | 4464 | 0.090 |
Why?
|
| Mothers | 5 | 2018 | 2208 | 0.090 |
Why?
|
| Verbal Learning | 2 | 2023 | 459 | 0.090 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6212 | 0.090 |
Why?
|
| Fatigue | 1 | 2018 | 1554 | 0.090 |
Why?
|
| Stachybotrys | 1 | 2010 | 1 | 0.090 |
Why?
|
| Maximal Midexpiratory Flow Rate | 2 | 2020 | 75 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 520 | 0.090 |
Why?
|
| Wechsler Scales | 2 | 2021 | 256 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2018 | 3576 | 0.090 |
Why?
|
| Students | 2 | 2017 | 1742 | 0.090 |
Why?
|
| Congenital Abnormalities | 2 | 2014 | 703 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 12807 | 0.090 |
Why?
|
| Southeastern United States | 3 | 2015 | 94 | 0.090 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1587 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2018 | 22245 | 0.090 |
Why?
|
| Mycotoxins | 1 | 2010 | 35 | 0.090 |
Why?
|
| Propensity Score | 2 | 2021 | 1972 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5789 | 0.080 |
Why?
|
| Lectins | 1 | 2012 | 490 | 0.080 |
Why?
|
| Risk Assessment | 12 | 2020 | 24272 | 0.080 |
Why?
|
| Methylmercury Compounds | 1 | 2011 | 103 | 0.080 |
Why?
|
| Alabama | 2 | 2024 | 111 | 0.080 |
Why?
|
| Sulfur Dioxide | 3 | 2019 | 178 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1243 | 0.080 |
Why?
|
| Vasodilation | 1 | 2014 | 969 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2013 | 649 | 0.080 |
Why?
|
| Exercise | 3 | 2023 | 5943 | 0.080 |
Why?
|
| Databases, Factual | 5 | 2017 | 8061 | 0.080 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 103 | 0.080 |
Why?
|
| Pilot Projects | 6 | 2019 | 8720 | 0.080 |
Why?
|
| Electrocardiography | 8 | 2017 | 6378 | 0.080 |
Why?
|
| Eligibility Determination | 1 | 2013 | 421 | 0.080 |
Why?
|
| Aorta | 1 | 2017 | 2041 | 0.080 |
Why?
|
| Visual Perception | 1 | 2017 | 1392 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2029 | 0.080 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 368 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2015 | 1050 | 0.080 |
Why?
|
| Uncertainty | 1 | 2014 | 764 | 0.080 |
Why?
|
| Hypotension, Orthostatic | 1 | 2012 | 258 | 0.080 |
Why?
|
| Fatty Acids | 3 | 2022 | 1807 | 0.080 |
Why?
|
| Catalase | 3 | 2016 | 215 | 0.080 |
Why?
|
| California | 2 | 2018 | 1435 | 0.080 |
Why?
|
| Cell Count | 2 | 2011 | 1826 | 0.080 |
Why?
|
| Memory Disorders | 1 | 2015 | 1193 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 474 | 0.080 |
Why?
|
| Bronchitis | 3 | 2014 | 193 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1659 | 0.080 |
Why?
|
| Calcinosis | 1 | 2017 | 1478 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3676 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2010 | 403 | 0.070 |
Why?
|
| Athletic Injuries | 1 | 2018 | 1244 | 0.070 |
Why?
|
| Oxygen | 2 | 2014 | 4251 | 0.070 |
Why?
|
| Glucose | 2 | 2017 | 4339 | 0.070 |
Why?
|
| Population Density | 2 | 2018 | 193 | 0.070 |
Why?
|
| Motor Vehicles | 1 | 2009 | 280 | 0.070 |
Why?
|
| Cadmium | 2 | 2022 | 218 | 0.070 |
Why?
|
| Microspheres | 2 | 2008 | 774 | 0.070 |
Why?
|
| Independent Living | 1 | 2012 | 584 | 0.070 |
Why?
|
| Heart Failure | 3 | 2024 | 11816 | 0.070 |
Why?
|
| Insect Control | 1 | 2007 | 28 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 489 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2012 | 4348 | 0.070 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2007 | 220 | 0.070 |
Why?
|
| Postural Balance | 1 | 2012 | 637 | 0.070 |
Why?
|
| DNA Damage | 1 | 2017 | 2464 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2018 | 1431 | 0.070 |
Why?
|
| Sex | 2 | 2017 | 52 | 0.070 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 20129 | 0.070 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4879 | 0.070 |
Why?
|
| Multivariate Analysis | 5 | 2019 | 12061 | 0.070 |
Why?
|
| Reaction Time | 1 | 2013 | 2085 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.070 |
Why?
|
| Overweight | 1 | 2018 | 2446 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2591 | 0.070 |
Why?
|
| Myocardium | 5 | 2011 | 4763 | 0.070 |
Why?
|
| Methylation | 2 | 2019 | 1074 | 0.070 |
Why?
|
| Ectromelia | 1 | 2006 | 28 | 0.070 |
Why?
|
| Attention | 2 | 2015 | 2413 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 1362 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1596 | 0.070 |
Why?
|
| Weight Loss | 1 | 2018 | 2711 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2007 | 191 | 0.070 |
Why?
|
| Public Housing | 1 | 2007 | 140 | 0.060 |
Why?
|
| Patella | 3 | 2016 | 317 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1519 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 21157 | 0.060 |
Why?
|
| Heart Diseases | 5 | 2014 | 2814 | 0.060 |
Why?
|
| Glutamate-Cysteine Ligase | 2 | 2016 | 24 | 0.060 |
Why?
|
| Teratogens | 2 | 2003 | 119 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 2 | 2022 | 553 | 0.060 |
Why?
|
| Spirometry | 2 | 2022 | 929 | 0.060 |
Why?
|
| Vitamin D | 1 | 2019 | 3270 | 0.060 |
Why?
|
| Lung Diseases | 3 | 2007 | 1941 | 0.060 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 57 | 0.060 |
Why?
|
| Macrophages | 2 | 2011 | 5782 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 887 | 0.060 |
Why?
|
| Memory, Short-Term | 2 | 2022 | 1004 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2007 | 216 | 0.060 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 143 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 1321 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4417 | 0.060 |
Why?
|
| Poverty Areas | 1 | 2006 | 268 | 0.060 |
Why?
|
| Rain | 2 | 2003 | 60 | 0.060 |
Why?
|
| Bronchitis, Chronic | 2 | 2002 | 81 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 2 | 2020 | 917 | 0.060 |
Why?
|
| Nutritional Status | 2 | 2018 | 1621 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 436 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2513 | 0.060 |
Why?
|
| Tibia | 3 | 2016 | 1071 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2017 | 6612 | 0.060 |
Why?
|
| Carbanilides | 1 | 2024 | 18 | 0.060 |
Why?
|
| Weight Gain | 1 | 2015 | 2356 | 0.060 |
Why?
|
| HIV Infections | 3 | 2020 | 17534 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2020 | 646 | 0.060 |
Why?
|
| Ghana | 2 | 2017 | 333 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2141 | 0.060 |
Why?
|
| Algorithms | 5 | 2019 | 14071 | 0.060 |
Why?
|
| Biomass | 2 | 2015 | 135 | 0.060 |
Why?
|
| Automobile Driving | 1 | 2009 | 442 | 0.060 |
Why?
|
| Quality Control | 2 | 2005 | 834 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2019 | 2605 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2009 | 991 | 0.060 |
Why?
|
| Midwestern United States | 1 | 2023 | 70 | 0.060 |
Why?
|
| Mid-Atlantic Region | 2 | 2014 | 24 | 0.060 |
Why?
|
| Face | 3 | 2005 | 1029 | 0.050 |
Why?
|
| Space-Time Clustering | 2 | 2016 | 45 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2006 | 855 | 0.050 |
Why?
|
| Bone and Bones | 2 | 2011 | 2559 | 0.050 |
Why?
|
| Age Determination by Teeth | 1 | 2003 | 11 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2011 | 838 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 12825 | 0.050 |
Why?
|
| Hexachlorobenzene | 1 | 2023 | 26 | 0.050 |
Why?
|
| Androgens | 2 | 2022 | 1279 | 0.050 |
Why?
|
| Ethmoid Bone | 1 | 2003 | 35 | 0.050 |
Why?
|
| Complex Mixtures | 1 | 2022 | 29 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2418 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2007 | 1159 | 0.050 |
Why?
|
| Tooth Abnormalities | 1 | 2003 | 56 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2024 | 140 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 271 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 2 | 2016 | 364 | 0.050 |
Why?
|
| Radiography, Panoramic | 1 | 2003 | 110 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 85 | 0.050 |
Why?
|
| Dermatoglyphics | 1 | 2002 | 20 | 0.050 |
Why?
|
| Age Determination by Skeleton | 1 | 2003 | 124 | 0.050 |
Why?
|
| Breath Tests | 2 | 2018 | 297 | 0.050 |
Why?
|
| Swimming | 1 | 2003 | 212 | 0.050 |
Why?
|
| Enterococcus | 1 | 2003 | 158 | 0.050 |
Why?
|
| Medicaid | 2 | 2013 | 2834 | 0.050 |
Why?
|
| Memory | 3 | 2017 | 2192 | 0.050 |
Why?
|
| Arteries | 1 | 2007 | 1121 | 0.050 |
Why?
|
| Sick Building Syndrome | 1 | 2021 | 17 | 0.050 |
Why?
|
| CpG Islands | 2 | 2019 | 1208 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2007 | 522 | 0.050 |
Why?
|
| Disease Models, Animal | 8 | 2017 | 18322 | 0.050 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 983 | 0.050 |
Why?
|
| Rodenticides | 1 | 2021 | 21 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2024 | 731 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13486 | 0.050 |
Why?
|
| Baltimore | 3 | 2007 | 233 | 0.050 |
Why?
|
| Research Design | 5 | 2024 | 6205 | 0.050 |
Why?
|
| Consciousness | 1 | 2007 | 602 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 1732 | 0.050 |
Why?
|
| Gene Dosage | 2 | 2020 | 1211 | 0.050 |
Why?
|
| Tanzania | 2 | 2016 | 1406 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2017 | 2272 | 0.050 |
Why?
|
| Fertilization | 1 | 2022 | 197 | 0.050 |
Why?
|
| Cephalometry | 1 | 2003 | 380 | 0.050 |
Why?
|
| Social Environment | 2 | 2017 | 1012 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2013 | 513 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11217 | 0.040 |
Why?
|
| Antioxidants | 3 | 2020 | 1671 | 0.040 |
Why?
|
| Drug Combinations | 2 | 2006 | 2078 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 16042 | 0.040 |
Why?
|
| Michigan | 1 | 2001 | 329 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2021 | 368 | 0.040 |
Why?
|
| Ethylene Glycol | 1 | 2000 | 31 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2018 | 7119 | 0.040 |
Why?
|
| Ferritins | 1 | 2023 | 600 | 0.040 |
Why?
|
| Skull Base | 1 | 2003 | 294 | 0.040 |
Why?
|
| Pliability | 1 | 2019 | 57 | 0.040 |
Why?
|
| Ohio | 2 | 2014 | 320 | 0.040 |
Why?
|
| Chromium | 1 | 2020 | 133 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 2143 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2002 | 592 | 0.040 |
Why?
|
| Problem Solving | 1 | 2022 | 442 | 0.040 |
Why?
|
| Hospitals | 2 | 2024 | 3885 | 0.040 |
Why?
|
| Maxilla | 1 | 2003 | 486 | 0.040 |
Why?
|
| Anxiety | 3 | 2023 | 4671 | 0.040 |
Why?
|
| Glioma | 2 | 2012 | 3498 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2015 | 6596 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 120 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 212 | 0.040 |
Why?
|
| Lagomorpha | 1 | 1999 | 7 | 0.040 |
Why?
|
| Emergency Service, Hospital | 3 | 2014 | 7869 | 0.040 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 242 | 0.040 |
Why?
|
| Cacodylic Acid | 1 | 2019 | 14 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 713 | 0.040 |
Why?
|
| Fertility | 1 | 2024 | 770 | 0.040 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 18 | 0.040 |
Why?
|
| Hospitals, Community | 3 | 1986 | 363 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2020 | 614 | 0.040 |
Why?
|
| Trace Elements | 1 | 2020 | 193 | 0.040 |
Why?
|
| Sensory Gating | 1 | 2019 | 47 | 0.040 |
Why?
|
| Antifibrinolytic Agents | 1 | 1982 | 289 | 0.040 |
Why?
|
| Pneumonia | 2 | 2002 | 2159 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3230 | 0.040 |
Why?
|
| Vitamins | 2 | 2023 | 1630 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 1732 | 0.040 |
Why?
|
| Canada | 2 | 2019 | 2123 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1101 | 0.040 |
Why?
|
| Illinois | 1 | 2018 | 120 | 0.040 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2018 | 54 | 0.040 |
Why?
|
| Geographic Information Systems | 2 | 2013 | 281 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 1180 | 0.040 |
Why?
|
| Mandible | 1 | 2003 | 747 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16721 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2018 | 148 | 0.040 |
Why?
|
| India | 2 | 2015 | 2335 | 0.040 |
Why?
|
| Vital Statistics | 1 | 2017 | 31 | 0.040 |
Why?
|
| Air Conditioning | 1 | 2017 | 54 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4628 | 0.040 |
Why?
|
| Rest | 2 | 2018 | 940 | 0.040 |
Why?
|
| New Hampshire | 1 | 2017 | 174 | 0.040 |
Why?
|
| Forecasting | 2 | 2019 | 2935 | 0.040 |
Why?
|
| Brain | 2 | 2015 | 27156 | 0.040 |
Why?
|
| Exercise Test | 1 | 2005 | 2185 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2675 | 0.040 |
Why?
|
| Mites | 1 | 2017 | 46 | 0.030 |
Why?
|
| Eosinophils | 1 | 2022 | 952 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1478 | 0.030 |
Why?
|
| Afghanistan | 1 | 2017 | 78 | 0.030 |
Why?
|
| Heating | 1 | 2017 | 103 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2002 | 789 | 0.030 |
Why?
|
| Rhode Island | 1 | 2017 | 351 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2006 | 2215 | 0.030 |
Why?
|
| Cyclins | 1 | 2019 | 604 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 857 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1752 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 325 | 0.030 |
Why?
|
| Quality of Life | 3 | 2024 | 13472 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 14643 | 0.030 |
Why?
|
| Netherlands | 1 | 2021 | 2277 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Middle East | 1 | 2017 | 234 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2019 | 373 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7866 | 0.030 |
Why?
|
| Estrogens | 1 | 2022 | 1528 | 0.030 |
Why?
|
| Dyspnea | 1 | 2024 | 1350 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3428 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2003 | 1424 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 5883 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 96 | 0.030 |
Why?
|
| New Jersey | 1 | 2016 | 296 | 0.030 |
Why?
|
| Israel | 1 | 2018 | 722 | 0.030 |
Why?
|
| Sperm Count | 1 | 2016 | 227 | 0.030 |
Why?
|
| Monte Carlo Method | 2 | 2012 | 1249 | 0.030 |
Why?
|
| Cats | 1 | 2017 | 972 | 0.030 |
Why?
|
| Urbanization | 1 | 2016 | 100 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2012 | 9101 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 347 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5509 | 0.030 |
Why?
|
| Wavelet Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 29922 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 254 | 0.030 |
Why?
|
| Skin Tests | 1 | 2017 | 630 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 1996 | 359 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 1424 | 0.030 |
Why?
|
| Uric Acid | 1 | 2021 | 809 | 0.030 |
Why?
|
| Maternal Age | 1 | 2018 | 804 | 0.030 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 513 | 0.030 |
Why?
|
| Veterans Health | 1 | 2016 | 216 | 0.030 |
Why?
|
| Time | 1 | 2016 | 550 | 0.030 |
Why?
|
| Oral Health | 1 | 2020 | 493 | 0.030 |
Why?
|
| Pipecolic Acids | 1 | 1995 | 77 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 771 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1982 | 1023 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2017 | 957 | 0.030 |
Why?
|
| North Carolina | 4 | 2007 | 329 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 235 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 434 | 0.030 |
Why?
|
| Sleep | 1 | 2010 | 4815 | 0.030 |
Why?
|
| Demography | 1 | 2019 | 1641 | 0.030 |
Why?
|
| Gambia | 1 | 2014 | 104 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 733 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
| Vitamin E | 1 | 2018 | 873 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2002 | 1938 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 354 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 828 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 737 | 0.030 |
Why?
|
| Motor Skills | 1 | 2016 | 519 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2023 | 2412 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.030 |
Why?
|
| Mice | 6 | 2022 | 81863 | 0.030 |
Why?
|
| Observer Variation | 2 | 2013 | 2613 | 0.030 |
Why?
|
| Cyprus | 1 | 2013 | 96 | 0.030 |
Why?
|
| Public Health Administration | 1 | 2015 | 242 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2014 | 507 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2432 | 0.030 |
Why?
|
| China | 1 | 2019 | 2383 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 355 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2013 | 211 | 0.030 |
Why?
|
| Intracranial Aneurysm | 1 | 1982 | 1271 | 0.030 |
Why?
|
| Parents | 2 | 2018 | 3595 | 0.030 |
Why?
|
| Registries | 2 | 2019 | 8344 | 0.030 |
Why?
|
| Life Style | 1 | 2024 | 3926 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 410 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 332 | 0.020 |
Why?
|
| Carbamazepine | 2 | 2005 | 224 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2024 | 81588 | 0.020 |
Why?
|
| Base Composition | 1 | 2012 | 291 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2015 | 806 | 0.020 |
Why?
|
| Health Services | 1 | 2017 | 755 | 0.020 |
Why?
|
| Comorbidity | 2 | 2017 | 10579 | 0.020 |
Why?
|
| Thromboplastin | 1 | 2014 | 289 | 0.020 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 135 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 45 | 0.020 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 212 | 0.020 |
Why?
|
| Plethysmography, Whole Body | 1 | 2011 | 25 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2014 | 347 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1374 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2868 | 0.020 |
Why?
|
| Pandemics | 2 | 2022 | 8729 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 586 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2012 | 182 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1805 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 975 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 624 | 0.020 |
Why?
|
| Species Specificity | 2 | 2010 | 2413 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2011 | 142 | 0.020 |
Why?
|
| New York City | 1 | 2013 | 736 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 464 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.020 |
Why?
|
| New York | 4 | 2004 | 879 | 0.020 |
Why?
|
| Oximetry | 1 | 2014 | 461 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3967 | 0.020 |
Why?
|
| Genomics | 1 | 2006 | 5924 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2230 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1916 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 648 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1753 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 939 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2012 | 607 | 0.020 |
Why?
|
| Lipids | 2 | 2016 | 3319 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2010 | 89 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3342 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1609 | 0.020 |
Why?
|
| Child Welfare | 1 | 2014 | 521 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 341 | 0.020 |
Why?
|
| Homocystine | 1 | 1989 | 21 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 903 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1389 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 227 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 707 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1963 | 0.020 |
Why?
|
| Feedback | 1 | 2013 | 797 | 0.020 |
Why?
|
| Epilepsy | 2 | 2002 | 3317 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 703 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1755 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2043 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2000 | 1542 | 0.020 |
Why?
|
| Public Health | 2 | 2015 | 2681 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
| San Francisco | 1 | 2008 | 165 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 974 | 0.020 |
Why?
|
| Insulin | 1 | 2023 | 6608 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2017 | 4141 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2014 | 492 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5502 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2014 | 1574 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2393 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2012 | 10092 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2010 | 6217 | 0.020 |
Why?
|
| Floors and Floorcoverings | 1 | 2007 | 27 | 0.020 |
Why?
|
| Weights and Measures | 1 | 2007 | 40 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3795 | 0.020 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 269 | 0.020 |
Why?
|
| Cadherins | 1 | 2012 | 901 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2013 | 556 | 0.020 |
Why?
|
| Beds | 1 | 2007 | 48 | 0.020 |
Why?
|
| Sputum | 1 | 2010 | 513 | 0.020 |
Why?
|
| Body Weight | 1 | 2018 | 4625 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 104 | 0.020 |
Why?
|
| Telomerase | 1 | 2012 | 750 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2007 | 193 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2008 | 316 | 0.020 |
Why?
|
| Missouri | 1 | 2007 | 113 | 0.020 |
Why?
|
| Small-Area Analysis | 1 | 2006 | 51 | 0.020 |
Why?
|
| Genotype | 2 | 2013 | 13034 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2006 | 103 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2014 | 785 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3341 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4443 | 0.020 |
Why?
|
| Deferoxamine | 1 | 2006 | 155 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2014 | 2764 | 0.020 |
Why?
|
| Learning | 1 | 2015 | 1754 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2003 | 8925 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2495 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2184 | 0.020 |
Why?
|
| Homocysteine | 1 | 1989 | 638 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3714 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1794 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 719 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2007 | 308 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 2013 | 858 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2006 | 2078 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1747 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3159 | 0.020 |
Why?
|
| Transportation | 1 | 2007 | 217 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2223 | 0.020 |
Why?
|
| Ventilation | 1 | 2006 | 129 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1989 | 742 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2009 | 893 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 915 | 0.010 |
Why?
|
| DNA Repair | 1 | 2014 | 2048 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 2902 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 2004 | 63 | 0.010 |
Why?
|
| Alleles | 1 | 2016 | 6894 | 0.010 |
Why?
|
| Rivers | 1 | 2004 | 65 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4497 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 663 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 445 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Chile | 1 | 2005 | 258 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4249 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5535 | 0.010 |
Why?
|
| Facies | 1 | 2005 | 224 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2014 | 2121 | 0.010 |
Why?
|
| Cytokines | 1 | 2019 | 7436 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 387 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2003 | 152 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2005 | 504 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 471 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6061 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 30220 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 2592 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2003 | 485 | 0.010 |
Why?
|
| Mental Health | 1 | 2018 | 3270 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 326 | 0.010 |
Why?
|
| Polysomnography | 1 | 2010 | 1868 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10740 | 0.010 |
Why?
|
| Acute Disease | 2 | 2009 | 7240 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 741 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2013 | 2856 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2004 | 382 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3803 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4356 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2013 | 12423 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 105 | 0.010 |
Why?
|
| Polyethylene | 1 | 2004 | 186 | 0.010 |
Why?
|
| Coronary Disease | 2 | 2012 | 5914 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2013 | 5302 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 410 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2009 | 1721 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2668 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2006 | 1058 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2004 | 362 | 0.010 |
Why?
|
| Food | 1 | 2007 | 764 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 1078 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2799 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2002 | 360 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12412 | 0.010 |
Why?
|
| Oregon | 3 | 1986 | 148 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2003 | 299 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2947 | 0.010 |
Why?
|
| Epiphyses | 1 | 2002 | 191 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2003 | 271 | 0.010 |
Why?
|
| Spleen | 1 | 2007 | 2294 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2003 | 676 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 18075 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1062 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2119 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4085 | 0.010 |
Why?
|
| Travel | 1 | 2006 | 806 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2000 | 131 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2006 | 2603 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7583 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3601 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9521 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2275 | 0.010 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1999 | 51 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15390 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 22337 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 665 | 0.010 |
Why?
|
| Diet | 1 | 2017 | 8085 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 1154 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2003 | 706 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 1638 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2004 | 1236 | 0.010 |
Why?
|
| Valproic Acid | 1 | 2001 | 444 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1999 | 411 | 0.010 |
Why?
|
| Water | 1 | 2004 | 1417 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4913 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 5741 | 0.010 |
Why?
|
| Epitopes | 1 | 2003 | 2526 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2007 | 3094 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2392 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5860 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1999 | 1527 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 5583 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1377 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1995 | 451 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15897 | 0.010 |
Why?
|
| Coma | 2 | 1986 | 485 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7071 | 0.010 |
Why?
|
| Liver | 1 | 2007 | 7570 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18979 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 5988 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5890 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1995 | 1345 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 4904 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1989 | 1528 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1999 | 9352 | 0.000 |
Why?
|
| Cerebral Infarction | 1 | 1986 | 967 | 0.000 |
Why?
|
| Ischemic Attack, Transient | 1 | 1986 | 872 | 0.000 |
Why?
|
| Employment | 1 | 1986 | 1110 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20706 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1986 | 1317 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1986 | 2429 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 36562 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 2654 | 0.000 |
Why?
|